MacroGenics
MGNX
173 hedge funds and large institutions have $1.8B invested in MacroGenics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 62 increasing their positions, 47 reducing their positions, and 14 closing their positions.
250% more funds holding in top 10
Funds holding in top 10: 2 → 7 (+5)
193% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 14
89% more call options, than puts
Call options by funds: $24.2M | Put options by funds: $12.8M
46% more capital invested
Capital invested by funds: $1.23B → $1.8B (+$571M)
32% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 47
18% more funds holding
Funds holding: 147 → 173 (+26)
5.15% more ownership
Funds ownership: 95.7% → 100.85% (+5.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$28.6M |
| 2 |
PA
Perceptive Advisors
New York
|
+$21.5M |
| 3 |
RI
RTW Investments
New York
|
+$18.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.5M |
| 5 |
BlackRock
New York
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$72.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$21.4M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$15.8M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$11.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$9.36M |
MGNX Hedge Fund Activity: Q1 2021 in Review
173 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2021, worth a combined $1.8B — up 46% from $1.23B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new MGNX positions and 14 closed out — a net gain of 27 holders — while 62 added to existing stakes and 47 trimmed.
The largest buyer was Victory Capital Management, adding an estimated $28.6M. The largest seller was Invesco, cutting an estimated $72.7M.
- 173 institutional investors held MacroGenics (MGNX) as of Q1 2021, up from 147 in Q4 2020.
- Funds reported $1.8B of MacroGenics stock for Q1 2021, up 46% quarter-over-quarter.
- 41 funds opened new MacroGenics positions in Q1 2021 and 14 closed out, a net change of +27 holders.
- The largest MacroGenics buyer in Q1 2021 was Victory Capital Management, an estimated $28.6M added.
- The largest MacroGenics seller in Q1 2021 was Invesco, an estimated $72.7M sold.
Based on aggregated 13F filings for Q1 2021.